Terms: = Kidney tumors AND ETV6, TEL/ABL, 2120, ENSG00000139083, P41212, TEL AND Treatment
15 results:
1. Report and follow-up on two new patients with congenital mesoblastic nephroma.
Serra G; Cimador M; Giuffrè M; Insinga V; Montante C; Pensabene M; Piro E; Salerno S; Schierz IAM; Corsello G
Ital J Pediatr; 2023 Sep; 49(1):124. PubMed ID: 37726782
[TBL] [Abstract] [Full Text] [Related]
2. A novel etv6-NTRK3 gene fusion in primary renal fibrosarcoma.
Jiang H
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(13):4705-4708. PubMed ID: 35856362
[TBL] [Abstract] [Full Text] [Related]
3. Mesenchymal neoplasms with NTRK and other kinase gene alterations.
Davis JL; Al-Ibraheemi A; Rudzinski ER; Surrey LF
Histopathology; 2022 Jan; 80(1):4-18. PubMed ID: 34958503
[TBL] [Abstract] [Full Text] [Related]
4. telmisartan-Induced Cytotoxicity via G
Tsujiya Y; Hasegawa A; Yamamori M; Okamura N
Biol Pharm Bull; 2021; 44(12):1878-1885. PubMed ID: 34853271
[TBL] [Abstract] [Full Text] [Related]
5. NTRK-Rearranged soft tissue neoplasms: A review of evolving diagnostic entities and algorithmic detection methods.
Surrey LF; Davis JL
Cancer Genet; 2022 Jan; 260-261():6-13. PubMed ID: 34794069
[TBL] [Abstract] [Full Text] [Related]
6. Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial.
Culine S; Harter V; Gravis G; Fléchon A; Chevreau C; Mahammedi H; Laguerre B; Guillot A; Joly F; Abadie-Lacourtoisie S; Geoffrois L; Fiore FD; Roubaud G; Barthélémy P; Voog E; Emambux S; Serrate C; Saldana C; Nguyen-Tan-Hon T; Loriot Y; Eymard JC; Huillard O; Rolland F; Houédé N; Spano JP; Demery ME; Vieillot S; L'Haridon T; Hilgers W; Allory Y; Pfister C;
Clin Genitourin Cancer; 2021 Dec; 19(6):554-562. PubMed ID: 34602349
[TBL] [Abstract] [Full Text] [Related]
7. Pediatric Renal tumors: Updates in the Molecular Era.
Treece AL
Surg Pathol Clin; 2020 Dec; 13(4):695-718. PubMed ID: 33183728
[TBL] [Abstract] [Full Text] [Related]
8. Adjuvant Maintenance Larotrectinib Therapy in 2 Children With NTRK Fusion-positive High-grade Cancers.
Carter-Febres M; Schneller N; Fair D; Solomon D; Perry A; Roy A; Linscott L; Alashari M; Kestle JR; Bruggers CS
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e987-e990. PubMed ID: 33093355
[TBL] [Abstract] [Full Text] [Related]
9. telmisartan Exacerbates Cisplatin-Induced Nephrotoxicity in a Mouse Model.
Hosoda A; Matsumoto Y; Toriyama Y; Tsuji T; Yoshida Y; Masamichi S; Kohno T
Biol Pharm Bull; 2020; 43(9):1331-1337. PubMed ID: 32879207
[TBL] [Abstract] [Full Text] [Related]
10. Modification of American Joint Committee on cancer prognostic groups for renal cell carcinoma.
Shao N; Wang HK; Zhu Y; Ye DW
Cancer Med; 2018 Nov; 7(11):5431-5438. PubMed ID: 30306741
[TBL] [Abstract] [Full Text] [Related]
11. Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.
Church AJ; Calicchio ML; Nardi V; Skalova A; Pinto A; Dillon DA; Gomez-Fernandez CR; Manoj N; Haimes JD; Stahl JA; Dela Cruz FS; Tannenbaum-Dvir S; Glade-Bender JL; Kung AL; DuBois SG; Kozakewich HP; Janeway KA; Perez-Atayde AR; Harris MH
Mod Pathol; 2018 Mar; 31(3):463-473. PubMed ID: 29099503
[TBL] [Abstract] [Full Text] [Related]
12. Translocation Renal Cell Carcinoma in a Child Previously Treated for Infantile Fibrosarcoma.
Ma J; Pan C; Yin M
Pediatr Dev Pathol; 2018; 21(4):418-422. PubMed ID: 28478739
[TBL] [Abstract] [Full Text] [Related]
13. [Fibrosarcoma in children and adolescents: different entities for the same name].
Thebaud E; Mezel A; Leroy X; Orbach D
Bull Cancer; 2012 Jun; 99(6):715-22. PubMed ID: 22640917
[TBL] [Abstract] [Full Text] [Related]
14. Safety of summer camp for children with chronic and/or life threatening illness.
Kinsella E; Zeltzer P; Dignan T; Winter J; Breatnach F; Bouffet E
Eur J Oncol Nurs; 2006 Sep; 10(4):304-10. PubMed ID: 16600684
[TBL] [Abstract] [Full Text] [Related]
15. Non-resectable congenital tumors with the etv6-NTRK3 gene fusion are highly responsive to chemotherapy.
McCahon E; Sorensen PH; Davis JH; Rogers PC; Schultz KR
Med Pediatr Oncol; 2003 May; 40(5):288-92. PubMed ID: 12652616
[TBL] [Abstract] [Full Text] [Related]